Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jul;3(3):256-8.
doi: 10.4103/0975-1483.83780.

Pharmacovigilance of herbal products in India

Affiliations

Pharmacovigilance of herbal products in India

P Wal et al. J Young Pharm. 2011 Jul.

Abstract

Herbal formulations being widely accepted therapeutic agents as antidiabetics, antiarthritics, hepatoprotectives, cough remedies, memory enhancers, and adaptogens. The commonest myth regarding herbal medicines is that these medicines are completely safe, and can therefore be safely consumed by the patient on his/her own, without a physician's prescription. This belief has led to large-scale self-medication by people all over the world, often leading to disappointing end-results, side-effects, or unwanted after-effects. There is an increasing awareness at several levels of the need to develop pharmacovigilance practices for herbal medicines. The current model of pharmacovigilance and its associated tools have been developed in relation to synthetic drugs, and applying these methods to monitoring the safety of herbal medicines presents unique challenges in addition to those described for conventional medicines. Several problems relate to the ways in which herbal medicines are named, perceived, sourced, and utilized. This may be because of differences in the use of nonorthodox drugs (e.g., herbal remedies) which may pose special toxicological problems, when used alone or in combination with other drugs. The purpose of pharmacovigilance is to detect, assess, and understand, and to prevent the adverse effects or any other possible drug-related problems, related to herbal, traditional, and complementary medicines.

Keywords: Adverse reaction; herbal medicines; pharmacovigilance.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Similar articles

Cited by

References

    1. Geneva: World Health Organization; 2004. WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems; p. 19.
    1. Williamson E. Drug interactions between herbal and prescription medicines. Drug Saf. 2003;26:1075–92. - PubMed
    1. Jordan SA, Cunningham DG, Marles RJ. Assessment of herbal medicinal products: Challenges, and opportunities to increase the knowledge base for safety sassessment. Toxicol Appl Pharmacol. 2010;243:198–216. - PubMed
    1. Health Canada, 2009a. Release of the guidance document for industry - reporting adverse reactions to marketed health products. 2009. Jul 09, [last accessed on 2009 Sep 28]. Available from: http://www.hc-sc.gc.ca/dhp-mps/pubs/medeff/_guide/2009-guidance-directri... .
    1. Farah MH, Edwards R, Lindquist M, Leon C, Shaw D. International monitoring of adverse health effects associated with herbal medicines. Pharmacoepidemiol Drug Saf. 2000;9:105–12. - PubMed